Karyopharm Therapeutics Inc. – Filings and Transcripts

NASDAQ: KPTI
Share price (7/2/26): $9.60
Market cap (7/2/26): $218 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Shelf registration

Shelf registration

Prospectus supplement

Ownership Filter

T. Rowe Price Investment Management, Inc.

Oliger Christy J.

News Filter

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment

Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction

Material Definitive Agreement, Other Events, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC